CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionP/E ratio is 119.25×, higher than 95% of its Medical Devices peers (median 35.3×)
- FinancialsAltman Z-Score 12.4: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.71BCNY1.15B · vs all stocks (USD)
Trailing P/E
119.25xvs Medical Devices peers
Revenue (TTM)
564.29MCNY83.92M · vs all stocks (USD)
Profit Margin
12.19%vs Medical Devices peers
Beta
0.5900xvs all stocks
52-Week Change
-43.49%vs all stocks
Market Capitalization
7.71BCNY1.15B · vs all stocks (USD)
Enterprise Value
7.24BCNY1.08B · vs all stocks (USD)
Trailing P/E
119.25xvs Medical Devices peers
Forward P/E
73.80xvs Medical Devices peers
PEG Ratio
0.2385xvs Medical Devices peers
Price to Sales (TTM)
14.13xvs Medical Devices peers
Price to Book (MRQ)
8.04xvs Medical Devices peers
Enterprise to Revenue
12.83xvs Medical Devices peers
Enterprise to EBITDA
48.51xvs Medical Devices peers
Gross Margin
69.81%vs Medical Devices peers
Profit Margin
12.19%vs Medical Devices peers
Operating Margin
23.43%vs Medical Devices peers
Return on Assets (TTM)
4.13%vs Medical Devices peers
Return on Equity (TTM)
7.31%vs Medical Devices peers
Revenue (TTM)
564.29MCNY83.92M · vs all stocks (USD)
Revenue per Share (TTM)
1.23CNYUpdated Aug 21, 2026Quarterly Revenue Growth
38.60%vs Medical Devices peers
Gross Profit (TTM)
381.90MCNY56.79M · vs all stocks (USD)
EBITDA (TTM)
153.07MCNY22.76M · vs all stocks (USD)
Net Income (TTM)
68.78MCNY10.23M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
723.90%vs Medical Devices peers
Operating Cash Flow (TTM)
183.54MCNY27.29M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
92.56MCNY13.76M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
32.18MCNYFY2025 · Dec 31, 2025Revenue
525.41MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
176.98MCNYFY2025 · Dec 31, 2025Gross Profit
348.42MCNYFY2025 · Dec 31, 2025Operating Income
75.17MCNY11.18M · vs all stocks (USD)
Pre-tax Income
68.45MCNYFY2025 · Dec 31, 2025Income Tax Expense
20.98MCNYFY2025 · Dec 31, 2025Net Income
47.47MCNYFY2025 · Dec 31, 2025EBIT
73.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
153.07MCNYFY2025 · Dec 31, 2025Research & Development
122.57MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
55.96MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.25MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.15MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.05MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
47.47MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-179.62KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
81.02MCNYFY2025 · Dec 31, 2025Free Cash Flow
35.26MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
396.41MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
47.47MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.05MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-16.59MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
25.10MCNYFY2025 · Dec 31, 2025Capital Expenditures
-45.77MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-45.77MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
67.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-76.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-4.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
3.55MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.74MCNYFY2025 · Dec 31, 2025Shares Outstanding
417.95MSharesUpdated Aug 21, 2026Float Shares
293.99MSharesUpdated Aug 21, 2026% Held by Insiders
30.44%vs all stocks
% Held by Institutions
4.95%vs all stocks
Total Cash (MRQ)
375.98MCNY55.91M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9000CNYUpdated Aug 21, 2026Total Debt (MRQ)
140.20MCNY20.85M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1317xvs Medical Devices peers
Current Ratio (MRQ)
2.54xvs Medical Devices peers
Book Value per Share (MRQ)
2.37CNYUpdated Aug 21, 2026Total Assets
1.35BCNY200.71M · vs all stocks (USD)
Total Current Assets
520.39MCNYFY2025 · Dec 31, 2025Total Liabilities
389.84MCNYFY2025 · Dec 31, 2025Total Non-current Assets
829.28MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
56.09MCNYFY2025 · Dec 31, 2025Total Current Liabilities
333.75MCNYFY2025 · Dec 31, 2025Cash
395.41MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
396.41MCNYFY2025 · Dec 31, 2025Accounts Receivable
25.14MCNYFY2025 · Dec 31, 2025Inventory
88.79MCNYFY2025 · Dec 31, 2025Accounts Payable
33.03MCNYFY2025 · Dec 31, 2025Short-term Debt
196.90MCNYFY2025 · Dec 31, 2025Other Current Liabilities
151.53KCNYFY2025 · Dec 31, 2025Long-term Debt
14.83MCNYFY2025 · Dec 31, 2025Common Stock (Book)
416.05MCNYFY2025 · Dec 31, 2025Retained Earnings
-193.53MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
959.83MCNY142.74M · vs all stocks (USD)
52-Week Low
14.59CNYUpdated Aug 21, 202652-Week High
39.54CNYUpdated Aug 21, 202652-Week Change
-43.49%vs all stocks
Beta
0.5900xvs all stocks
50-Day MA
18.08CNYUpdated Aug 21, 2026200-Day MA
20.22CNYUpdated Aug 21, 2026Avg 10-Day Volume
16.31MSharesUpdated Aug 21, 2026Avg 30-Day Volume
14.14MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1600CNYUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 119.25×, higher than 95% of its Medical Devices peers (median 35.3×)Significant
P/E ratio: 119.25Industry median: 35.30Industry P95: 117.323Peers compared: 59.00
Financial Health
Altman Z-Score 12.4: safe zoneNotable
Altman Z-Score: 12.40
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MeiraGTx Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shantou Institute of Ultrasonic Instruments Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alvotech S.A.
Tier 1ProductionApproval-Gated PipelineRule
SSY Group Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gen Ilac ve Saglik Urunleri A.S.
Tier 1ProductionApproval-Gated PipelineRule
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Savara Inc.
Tier 1ProductionApproval-Gated PipelineRule
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Colgate-Palmolive (India) Ltd.
2 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtIndustry-Benchmarked ROA and Margin Elevated
AP Memory Technology Corp.
2 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtIndustry-Benchmarked ROA and Margin Elevated
Cricut, Inc.
2 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtIndustry-Benchmarked ROA and Margin Elevated